Shibata H., Yoshioka Y., Ohkawa A., Minowa K., Mukai Y., Abe Y., Taniai M., Nomura T., Kayamuro H., Nabeshi H., Sugita T., Imai S., Nagano K., Yoshikawa T., Fujita T., Nakagawa S., Yamamoto A., Ohta T., Hayakawa T., Mayumi T., Vandeenabeele P., Aggarwal BB., Nakamura T., Yamagata Y., Tsunoda S., Kamada H., Tsutsumi Y.
Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist.
J. Biol. Chem., 283:998-1007, 2008. [PubMed]

Sugita T., Yoshikawa T., Mukai Y., Yamanada N., Imai S., Nagano K., Yoshida Y., Shibata H., Yoshioka Y., Nakagawa S., Kamada H., Tsunoda S., Tsutsumi Y.
Comparative Study of the Protein Transduction Domains-Mediated Molecular Transduction.
Br. J. Pharmacol., 153(6):1143-52, 2008. [PubMed]

Abe Y., Yoshikawa T., Kamada H., Shibata H., Nomura T., Minowa K., Kayamuro H., Katayama K., Miyoshi H., Mukai Y., Yoshioka Y., Nakagawa S., Tsunoda S., Tsutsumi Y.
Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activity.
J. Immunol. Methods., 335(1-2):71-8, 2008. [PubMed]

Yoshikawa T., Sugita T., Mukai Y., Yamanada N., Nagano K., Nabeshi H., Yoshioka Y., Nakagawa S., Abe Y., Kamada H., Tsunoda S., Tsutsumi Y.
Organelle-targeted delivery of biological macromolecules using the protein transduction domain: Potential applications for peptide aptamer delivery into the nucleus.
J. Mol. Biol., 380(5):777-782, 2008. [PubMed]

Imai S., Mukai Y., Takeda T., Abe Y., Nagano K., Kamada H., Nakagawa S., Tsunoda S., Tsutsumi Y.
The effect of protein properties on display efficiency using the M13 phage display system.
Pharmazie., 63(10):760-764, 2008. [PubMed]

Shibata H., Yoshioka Y., Ohkawa A., Abe Y., Nomura T., Mukai Y., Nakagawa S., Taniai M., Ohta T., Mayumi T., Kamada H., Tsutsumi Y.
The therapeutic effect of TNFR1-selective antagonistic mutant TNF-α in murine hepatitis models.
Cytokine., 44(2):229-233, 2008. [PubMed]

Mukai Y., Shibata H., Nakamura T., Yoshioka Y., Abe Y., Nomura T., Taniai M., Ohta T., Ikemizu S., Nakagawa S., Tsunoda S., Kamada H., Yamagata Y., Tsutsumi Y.
Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
J. Mol. Biol., 385:1221?1229, 2009.[PubMed]

永田　諭志
Onda M, Beers R, Xiang L, Nagata S, Wang Q, Pastan I (2008) An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes. Proceedings of National Academy of Sciences of the United States of America 105, 11311-11316.[PubMed]

Matsushita K, Margulies I, Onda M, Nagata S, Stetler-Stevenson M, Kreitman RJ (2008) Soluble CD22 as a tumor marker for hairy cell leukemia. Blood, 112, 2272-2277.[PubMed]

Das S, Hahn Y, Walker D, Nagata S, Willingham MC, Peehl DM, Bera T, Lee B, Pastan I (2008) Topology of NGEP, a prostate specific cell:cell junction protein widely expressed in many cancers of different grade level. Cancer Research, 68, 6306-6312.[PubMed]

Ise T, Das S, Nagata S, Maeda H, Lee Y, Onda M, Anver MR, Bera TK, Pastan I (2008) Expression of POTE protein in human testis detected by novel monoclonal antibodies. Biochemical and Biophysical Research Communications, 365, 603-608.[PubMed]

Du X,* Nagata S,* Ise T, Stetler-Stevenson M and Pastan I (2008) FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia and B-cell non-Hodgkin’s lymphoma as a target of immunotoxins. Blood 111, 338-343. (*equal contribution acknowledged)[PubMed]